ELEKTA AND IMPAC MEDICAL SYSTEMS AGREE TO JOINTLY DEVELOP DICOM-RT LINEAR ACCELERATOR INTERFACE
ELEKTA AND IMPAC MEDICAL SYSTEMS AGREE TO JOINTLY DEVELOP DICOM-RTLINEAR ACCELERATOR INTERFACEInterface will be the first complete linear accelerator DICOM-RTinterface and will facilitate connectivity between Elekta's digitallinear accelerators and IMPAC's Oncology Management SystemElekta, a world-leading supplier of advanced and innovative radiationoncology solutions and services, and IMPAC Medical Systems, Inc.(NASDAQ:IMPC), a leading provider of information management solutionsfor cancer care, announce today their agreement to use a full DICOM-RTcompliant specification for the development of an interface to connectthe Elekta product lines of digital linear accelerators (ElektaSynergy(TM) and Precise Treatment System(TM)) with IMPAC's oncologyinformation management products.This interface will provide a vendor-independent means of facilitatinguniversal connectivity of next-generation radiation treatment devices,such as linear accelerators and proton therapy delivery systems as wellas treatment simulation devices to information management systems. IMPACand Elekta are the first to formally adopt the standard. Both companieshave been working together towards this goal over the past months. "This agreement will further improve seamless connectivity forcustomers by expanding the use of new technology systems as well asshorten the start-up time for new and expanding cancer centers ," statedTomas Puusepp, Executive VP Sales, Marketing & Service at Elekta. "Moreimportantly, patients will benefit from a more rapid deployment ofleading edge treatments. We encourage all oncology vendors to joinElekta and IMPAC in adopting this standard.""This is a collaborative development effort aimed at improving theprocess of managing increasingly complex cancer treatment techniques,"stated Joseph K. Jachinowski, president and CEO of IMPAC. "IMPAC isdelighted to team with Elekta in this agreement to adopt the DICOM-RTstandard in a complete manner," he added.******For further information, please contact:International: Peter Ejemyr, Group VP Corporate Communications, ElektaAB (publ),Phone: +46 733 611 000, e-mail: [email protected] States: Lars Jonsteg, VP Investor Relations North America,Elekta, USAPhone: +1 770-670-2419, e-mail: [email protected] Elekta:Elekta is a world-leading supplier of advanced and innovative radiationoncology and neurosurgery solutions and services for precise treatmentof cancer and brain disorders. Elekta's solutions are clinicallyeffective, cost efficient and gentle to the patient.For additional information about Elekta, please visit www.elekta.comAbout IMPAC Medical SystemsIMPAC Medical Systems, Inc. is a leading provider of specialized ITsolutions that streamline both clinical and business operations to helpimprove the process of delivering quality patient care. With openintegration to multiple healthcare data and imaging systems, IMPACoffers a comprehensive IT solution that includes specialized electroniccharting, full-featured practice management, clinical laboratorymanagement, and outcomes reporting. Supporting over 1600 installationsworldwide, IMPAC delivers practical solutions that deliver betteroverall communication, process efficiency and quality patient care.For more information about IMPAC Medical Systems' products and services,please call +1-650-623-8800 or visit www.impac.com.------------------------------------------------------------This information was brought to you by Waymaker http://www.waymaker.netThe following files are available for download:http://www.waymaker.net/bitonline/2003/12/03/20031203BIT00020/wkr0001.doc http://www.waymaker.net/bitonline/2003/12/03/20031203BIT00020/wkr0002.pdf